HomeNewsBusinessAs COVID-19 disruptions ease, airlines in India face turbulence from protesting employees

As COVID-19 disruptions ease, airlines in India face turbulence from protesting employees

Staff at IndiGo, GoFirst, Air India and SpiceJet have, in the past, expressed discontent by not reporting for work, or taking mass leaves, which disrupted the operations of these airlines.

July 14, 2022 / 20:33 IST
Story continues below Advertisement
Representative image (Image: Reuters)
Representative image (Image: Reuters)

Airlines in India are once again making headlines for the wrong reasons, as nearly all incumbent players in the Indian aviation industry have faced turbulence in the past month, with their employees protesting against the lack of reinstatement of their salaries that were cut during the outbreak of the COVID-19 pandemic.

Employees of IndiGo, GoFirst, Air India and SpiceJet have all expressed their discontent in the past by not reporting for work, or taking "mass leaves", which disrupted the operations of these airlines.

Story continues below Advertisement

IndiGo 

It all started when InterGlobe Aviation-owned IndiGo witnessed delays in its flights across the country on July 2 and July 3, with more than 56 percent of the airline's flights reporting delays on July 2.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show